Calcitriol, the Active Metabolite of Vitamin D₃, Inhibits Dry Eye Related Corneal Inflammation In Vivo and In Vitro

REFERENCES

• Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–412.
   PubMedGoogle Scholar
• Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110:1096–1101.
   PubMed Web of Science ®Google Scholar
• Uchino M, Schaumberg DA, Dogru M, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology. 2008;115:1982–1988.
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127:763–768.
   PubMed Web of Science ®Google Scholar
• Yagci A, Gurdal C. The role and treatment of inflammation in dry eye disease. Int Ophthalmol. 2014;34:1291–1301.
   PubMed Web of Science ®Google Scholar
• Pasparakis M. Role of NF-kappaB in epithelial biology. Immunol Rev. 2012;246:346–358.
   PubMed Web of Science ®Google Scholar
• Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.
   PubMed Web of Science ®Google Scholar
• Lam H, Bleiden L, De Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198–205.e1.
   PubMed Web of Science ®Google Scholar
• Enriquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–873.
   PubMed Web of Science ®Google Scholar
• Al-Saedi Z, Zimmerman A, Bachu RD, et al. Dry eye disease: present challenges in the management and future trends. Curr Pharm Des. 2016;22:4470–4490.
   PubMed Web of Science ®Google Scholar
• Aragona P, Stilo A, Ferreri F, Mobrici M. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren’s syndrome patients. Eye. 2005;19:535–539.
   PubMed Web of Science ®Google Scholar
• Szymczak I, Pawliczak R. The active metabolite of vitamin D3 as a potential immunomodulator. Scand J Immunol. 2016;83:83–91.
   PubMed Web of Science ®Google Scholar
• Wei R, Christakos S. Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients. 2015;7:8251–8260.
   PubMed Web of Science ®Google Scholar
• Xue ML, Zhu H, Thakur A, Willcox M. 1 alpha,25-Dihydroxyvitamin D3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol Cell Biol. 2002;80:340–345.
   PubMed Web of Science ®Google Scholar
• Reins RY, Baidouri H, McDermott AM. Vitamin D activation and function in human corneal epithelial cells during TLR-induced inflammation. Invest Ophthalmol Vis Sci. 2015;56:7715–7727.
   PubMed Web of Science ®Google Scholar
• Nebbioso M, Buomprisco G, Pascarella A, Pescosolido N. Modulatory effects of 1,25-dihydroxyvitamin D3 on eye disorders: a critical review. Crit Rev Food Sci Nutr. 2017;57:559–565.
   PubMed Web of Science ®Google Scholar
• Yoon SY, Bae SH, Shin YJ, et al. Low serum 25-hydroxyvitamin D levels are associated with dry eye syndrome. PLoS One. 2016;11:e0147847.
   PubMed Web of Science ®Google Scholar
• Yildirim P, Garip Y, Karci AA, Guler T. Dry eye in vitamin D deficiency: more than an incidental association. Int J Rheum Dis. 2016;19:49–54.
   PubMed Web of Science ®Google Scholar
• Kurtul BE, Ozer PA, Aydinli MS. The association of vitamin D deficiency with tear break-up time and Schirmer testing in non-Sjogren dry eye. Eye. 2015;29:1081–1084.
   PubMed Web of Science ®Google Scholar
• Jin KW, Ro JW, Shin YJ, Hyon JY, Wee WR, Park SG. Correlation of vitamin D levels with tear film stability and secretion in patients with dry eye syndrome. Acta Ophthalmol (Copenh). 2017;95:e230–e235.
   PubMed Web of Science ®Google Scholar
• Bae SH, Shin YJ, Kim HK, Hyon JY, Wee WR, Park SG. Vitamin D supplementation for patients with dry eye syndrome refractory to conventional treatment. Sci Rep. 2016;6:33083.
   PubMed Web of Science ®Google Scholar
• Lemp MA Report of the national eye institute/industry workshop on clinical trials in dry eyes. The CLAO journal: official publication of the Contact Lens Association of Ophthalmologists, Inc 1995;21:221–232.
   Google Scholar
• Bron AJ, Abelson MB, Ousler G, et al. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:108–152.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Kim SK, Dana R, et al. International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013;3:3419.
   PubMed Web of Science ®Google Scholar
• Laria C, Alio JL, Ruiz-Moreno JM. Combined non-steroidal therapy in experimental corneal injury. Ophthalmic Res. 1997;29:145–153.
   PubMed Web of Science ®Google Scholar
• Xiao X, He H, Lin Z, et al. Therapeutic effects of epidermal growth factor on benzalkonium chloride-induced dry eye in a mouse model. Invest Ophthalmol Vis Sci. 2012;53:191–197.
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Corrales RM, Villarreal AL, et al. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci. 2006;47:2847–2856.
   PubMed Web of Science ®Google Scholar
• Li J, Ruzhi D, Hua X, et al. Blueberry component pterostilbene protects corneal epithelial cells from inflammation via anti-oxidative pathway. Sci Rep. 2016;6:19408.
   PubMed Web of Science ®Google Scholar
• Wei Y, Asbell PA. The core mechanism of dry eye disease is inflammation. Eye Contact Lens. 2014;40:248–256.
   PubMed Web of Science ®Google Scholar
• Liu H, Begley C, Chen M, et al. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci. 2009;50:3671–3679.
   PubMed Web of Science ®Google Scholar
• Warcoin E, Clouzeau C, Roubeix C, et al. Hyperosmolarity and benzalkonium chloride differently stimulate inflammatory markers in conjunctiva-derived epithelial cells in vitro. Ophthalmic Res. 2017;58:40–48.
   PubMed Web of Science ®Google Scholar
• Reins RY, Mesmar F, Williams C, McDermott AM. Vitamin D induces global gene transcription in human corneal epithelial cells: implications for corneal inflammation. Invest Ophthalmol Vis Sci. 2016;57:2689–2698.
   PubMed Web of Science ®Google Scholar
• Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5:975–979.
   PubMed Web of Science ®Google Scholar
• Lambiase A, Micera A, Sacchetti M, Mantelli F, Bonini S. Toll-like receptors in ocular surface diseases: overview and new findings. Clin Sci. 2011;120:441–450.
   PubMed Web of Science ®Google Scholar
• Redfern RL, Patel N, Hanlon S, et al. Toll-like receptor expression and activation in mice with experimental dry eye. Invest Ophthalmol Vis Sci. 2013;54:1554–1563.
   PubMed Web of Science ®Google Scholar
• Lee HS, Hattori T, Park EY, Stevenson W, Chauhan SK, Dana R. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci. 2012;53:5632–5640.
   PubMed Web of Science ®Google Scholar
• Redfern RL, Barabino S, Baxter J, Lema C, McDermott AM. Dry eye modulates the expression of toll-like receptors on the ocular surface. Exp Eye Res. 2015;134:80–89.
   PubMed Web of Science ®Google Scholar